Medscape Hematology-Oncology Headlines This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Is Primary Tumor Resection Beneficial in Stage IV CRC? Is Primary Tumor Resection Beneficial in Stage IV CRC?
Primary tumor resection before chemotherapy does not prolong survival in patients with CRC and unresectable metastases, combined results from two trials indicate.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Cancer-causing Chemical Found in Clinique, Clearasil Acne Treatments, U.S. Lab Reports Cancer-causing Chemical Found in Clinique, Clearasil Acne Treatments, U.S. Lab Reports
High levels of cancer-causing chemical benzene were detected in some acne treatments from brands including Estee Lauder ' s Clinique, Target ' s Up& Up and Reckitt...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 6, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Latest J & J Talc Trial Ends With Hung Jury Latest J & J Talc Trial Ends With Hung Jury
The latest trial over claims that Johnson& Johnson ' s talc products cause cancer ended in a mistrial on Tuesday, as a Florida state court jury said it could not agree on...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Community: Key to Keeping Up-to-Date in Thoracic Oncology Community: Key to Keeping Up-to-Date in Thoracic Oncology
Dr Mark Kris discusses the importance of community in keeping up-to-date with the latest news and data in thoracic cancer.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

Can Changes to Chemo Improve Tolerability in Older Patients? Can Changes to Chemo Improve Tolerability in Older Patients?
Reducing treatment doses and altering treatment schedules can help reduce adverse events and improve tolerability in older patients with advanced cancer, a new study suggested.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

' Less Is More' in Myeloma'Less Is More' in Myeloma
Dr. Mohyuddin discusses " less is more " clinical trials that challenge conventional practices and have shown improved outcomes with lower drug dosages.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Oophorectomy Saves Lives in Women With BRCA1/2 Mutations Oophorectomy Saves Lives in Women With BRCA1/2 Mutations
In women with BRCA1/2 pathogenic variants, preventive bilateral oophorectomy was associated with a 68% lower risk for death from any cause, a large cohort study found.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 5, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

PATHFINDER: Not Quite Hitting the Mark? PATHFINDER: Not Quite Hitting the Mark?
Dr Kathy Miller discusses the potential mismatch between results and conclusions from the PATHFINDER study.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news

US Urges Court to Preserve Obamacare Mandate to Cover Cancer Screenings, HIV Drugs US Urges Court to Preserve Obamacare Mandate to Cover Cancer Screenings, HIV Drugs
President Joe Biden ' s administration on Monday urged a U.S. appeals court to preserve a federal mandate that requires health insurers to cover preventive care services...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Family Medicine/Primary Care Source Type: news

US Court to Weigh Obamacare Mandate to Cover HIV Drug, Cancer Screenings US Court to Weigh Obamacare Mandate to Cover HIV Drug, Cancer Screenings
President Joe Biden ' s administration on Monday is set to urge a U.S. appeals court to preserve a federal mandate that requires health insurers to cover preventive care...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Family Medicine/Primary Care Source Type: news

Outside the Guidelines: Denosumab Overuse in Prostate Cancer Outside the Guidelines: Denosumab Overuse in Prostate Cancer
Many men with castration-sensitive prostate cancer receive the bone-modifying agent to prevent skeletal-related events, but that practice is not recommended and costs Medicare millions annually.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

How Often Should Patients Receive Imaging After Spine SBRT? How Often Should Patients Receive Imaging After Spine SBRT?
A new study suggested a tailored MRI approach based on patients ' progression risk after stereotactic body radiotherapy for spinal metastases.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 4, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

New Tool Gauges Post –CAR T Relapse Risk in Multiple Myeloma New Tool Gauges Post –CAR T Relapse Risk in Multiple Myeloma
A simple prediction model developed with US and European cohorts effectively predicted relapse risk in multiple myeloma patients post anti-BCMA CAR-T therapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 1, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Many European Cancer Drugs Offer No Added Benefit Many European Cancer Drugs Offer No Added Benefit
Two fifths of oncology drugs approved by the EMA over the past 25 years don ' t offer an added benefit, while their costs may be burdening health systems.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 29, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Low-Dose Aspirin Associated With Reduced CRC Risk Low-Dose Aspirin Associated With Reduced CRC Risk
A Norwegian nationwide study revealed that the impact of low-dose aspirin use was greatest for metastatic colorectal cancer and increased with a longer duration of use.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 29, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news